Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Dostawy produktów leczniczych

Part no. 1: Non-pegylated liposomal doxorubicin

Part no. 2: Denosumab

Part no. 3: Abiraterone octane

Part no. 4: Aprepitant

Part no. 5: Zoledronic acid

Part no. 6: Rituximab

Part no. 7: Azacitidine

Part no. 8: Tretinoin

Part no. 9: Trabectedin

Part no. 10: Mesna

Part no. 11: Peginterferon alfa-2a

Part no. 12: Vinorelbine

Part no. 13: Various medicinal products

Part no. 14: Panitumumab

Part no. 15: Denosumab

Part no. 16: Aflibercept

Part no. 17: Bosutinib

Part no. 18: Paclitaxel in the form of a nano-particle complex with albumin